sanofi-aventis U.S. LLC et al v. Shilpa Medicare Limited
| Genzyme Corporation, Aventisub LLC, sanofi-aventis U.S. LLC and Sanofi |
| Shilpa Medicare Limited |
| 1:2019cv01975 |
| October 17, 2019 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 24, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 STIPULATION TO EXTEND TIME to Respond to Complaint to December 17, 2019 - filed by Aventisub LLC, Genzyme Corporation, Sanofi, sanofi-aventis U.S. LLC. (Bove, Jeffrey) |
SO ORDERED re #7 STIPULATION TO EXTEND TIME to Respond to Complaint to December 17, 2019 (Set/Reset Answer Deadlines: Shilpa Medicare Limited answer due 12/17/2019). ORDERED by Judge Maryellen Noreika on 10/24/2019. (dlw)
|
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 6 AFFIDAVIT of Service for Declaration of Mailing Pursuant to 10 Del. C. s 3104 served on Shilpa Medicare Ltd. on 10/17/2019, filed by Aventisub LLC, Genzyme Corporation, Sanofi, sanofi-aventis U.S. LLC. (Attachments: #1 Exhibit A, #2 Exhibit B)(Bove, Jeffrey) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Aventisub LLC, Genzyme Corporation, and sanofi-aventis U.S. LLC filed by Aventisub LLC, Genzyme Corporation, sanofi-aventis U.S. LLC. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 B2. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 4, 2019. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 3/4/2022. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT filed against Shilpa Medicare Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2757420.) - filed by sanofi-aventis U.S. LLC, Aventisub LLC, Sanofi, and Genzyme Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(mal) |
| Summons Issued with Magistrate Consent Notice attached as to Shilpa Medicare Limited on 10/17/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
